Literature DB >> 15280497

Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions.

Bethany Unger1, Paula Traktman.   

Abstract

The 70-amino-acid A13L protein is a component of the vaccinia virus membrane. We demonstrate here that the protein is expressed at late times of infection, undergoes phosphorylation at a serine residue(s), and becomes encapsidated in a monomeric form. Phosphorylation is dependent on Ser40, which lies within the proline-rich motif SPPP. Because phosphorylation of the A13 protein is only minimally affected by disruption of the viral F10 kinase or H1 phosphatase, a cellular kinase is likely to be involved. We generated an inducible recombinant in which A13 protein expression is dependent upon the inclusion of tetracycline in the culture medium. Repression of the A13L protein spares the biochemical progression of the viral life cycle but arrests virion morphogenesis. Virion assembly progresses through the formation of immature virions (IVs); however, these virions do not acquire nucleoids, and DNA crystalloids accumulate in the cytoplasm. Further development into intracellular mature virions is blocked, causing a 1,000-fold decrease in the infectious virus yield relative to that obtained in the presence of the inducer. We also determined that the temperature-sensitive phenotype of the viral mutant Cts40 is due to a nucleotide transition within the A13L gene that causes a Thr(48)-->Ile substitution. This substitution disrupts the function of the A13 protein but does not cause thermolability of the protein; at the nonpermissive temperature, virion morphogenesis arrests at the stage of IV formation. The A13L protein, therefore, is part of a newly recognized group of membrane proteins that are dispensable for the early biogenesis of the virion membrane but are essential for virion maturation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280497      PMCID: PMC479082          DOI: 10.1128/JVI.78.16.8885-8901.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors.

Authors:  T J Koerner; J E Hill; A M Myers; A Tzagoloff
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

4.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.

Authors:  W J Boyle; P van der Geer; T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  Rifampicin prevents virosome localization of L65, an essential vaccinia virus polypeptide.

Authors:  J N Miner; D E Hruby
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

6.  Regulation of a modified CaMV 35S promoter by the Tn10-encoded Tet repressor in transgenic tobacco.

Authors:  C Gatz; A Kaiser; R Wendenburg
Journal:  Mol Gen Genet       Date:  1991-06

7.  Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA. Viral nuclease cleavage sites in cruciform structures.

Authors:  M Merchlinsky; C F Garon; B Moss
Journal:  J Mol Biol       Date:  1988-02-05       Impact factor: 5.469

8.  Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant.

Authors:  P Traktman; K Liu; J DeMasi; R Rollins; S Jesty; B Unger
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.

Authors:  Y Zhang; J G Keck; B Moss
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Tn10-encoded tet repressor can regulate an operator-containing plant promoter.

Authors:  C Gatz; P H Quail
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  26 in total

1.  Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis.

Authors:  Almira Punjabi; Paula Traktman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Authors:  Sayuri E M Kato; Nissin Moussatche; Susan M D'Costa; Travis W Bainbridge; Cindy Prins; Audra L Strahl; Amber N Shatzer; Alyson J Brinker; Nicole E Kay; Richard C Condit
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

3.  The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry.

Authors:  R Jeremy Nichols; Eleni Stanitsa; Bethany Unger; Paula Traktman
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

4.  Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis.

Authors:  Susan M D'Costa; Travis W Bainbridge; Sayuri E Kato; Cindy Prins; Karen Kelley; Richard C Condit
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

5.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

Review 6.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

7.  Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity.

Authors:  Nadi T Wickramasekera; Paula Traktman
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

8.  Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis.

Authors:  Shannon McNulty; William Bornmann; Jill Schriewer; Chas Werner; Scott K Smith; Victoria A Olson; Inger K Damon; R Mark Buller; John Heuser; Daniel Kalman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

Review 9.  Viral miniproteins.

Authors:  Daniel DiMaio
Journal:  Annu Rev Microbiol       Date:  2014-04-10       Impact factor: 15.500

10.  Functional characterization of the vaccinia virus I5 protein.

Authors:  Bethany Unger; R Jeremy Nichols; Eleni S Stanitsa; Paula Traktman
Journal:  Virol J       Date:  2008-12-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.